Post-approval studies (Phase 4)Ended earlyNCT04235322What this trial is testingStudy of 2LHERP® in Genital Herpes InfectionsWho this might be right forHerpes Simplex, Genital Labo'Life 6
Not applicableStudy completedNCT04239521What this trial is testingThe Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataWho this might be right forAlopecia AreataDepressive EpisodeRecurrent Depressive Disorder+33 more Momentum Data 51,955
Not applicableStudy completedNCT05500053What this trial is testingThe Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic DiseaseWho this might be right forGenital HerpesPatient Engagement Rational Vaccines Inc 68
Large-scale testing (Phase 3)Study completedNCT00164424What this trial is testingEpisodic Acyclovir Therapy for Genital UlcersWho this might be right forHIV InfectionsUlcerHerpes Simplex Centers for Disease Control and Prevention 613
Early research (Phase 1)Active Not RecruitingNCT05432583What this trial is testingA Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes LesionsWho this might be right forGenital Herpes Simplex Type 2 BioNTech SE 318
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04979975What this trial is testingEvaluating Safety and Efficacy of Repeat Doses of UB-621in Adult Patients With Recurrent Genital HerpesWho this might be right forRecurrent Genital Herpes UBP Greater China (Shanghai) Co., Ltd 200
Not applicableStudy completedNCT02053142What this trial is testingAcyclovir Therapy for Genital Herpes Ulcers in HIV Negative African WomenWho this might be right forUlcers of Female Genital Organs University of North Carolina, Chapel Hill 74
Large-scale testing (Phase 3)Study completedNCT00306787What this trial is testingEfficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital HerpesWho this might be right forGenital Herpes Novartis Pharmaceuticals 1,179
Early research (Phase 1)Study completedNCT06385327What this trial is testingAssess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital HerpesWho this might be right forRecurrent Genital Herpes Simplex Type 2 Assembly Biosciences 115
Early research (Phase 1)Study completedNCT06698575What this trial is testingAssess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital HerpesWho this might be right forRecurrent Genital Herpes Simplex Type 2 Assembly Biosciences 103
Testing effectiveness (Phase 2)UnknownNCT04714060What this trial is testingUB-621, a New Type of Anti-herpes Simplex Virus (HSV) Monoclonal Antibody for the Use in the Treatment of Adult Recurrent HSV-2 Infections of the GenitalsWho this might be right forRecurrent Genital Herpes UBP Greater China (Shanghai) Co., Ltd 44
Testing effectiveness (Phase 2)Study completedNCT00486200What this trial is testingA Study With ASP2151 in Subjects With Recurrent Episodes of Genital HerpesWho this might be right forHerpes Genitalis Astellas Pharma Inc 695
Testing effectiveness (Phase 2)Study completedNCT01687595What this trial is testingBiological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital HerpesWho this might be right forHerpes Simplex Type 2 Agenus Inc. 80
Not applicableStudy completedNCT00803543What this trial is testingEffect of Valacyclovir in the Reduction of HSV-2 Recurrence and SheddingWho this might be right forHIVHIV Infections University of Alabama at Birmingham 103
Not applicableStudy completedNCT00002404What this trial is testingThe Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected PatientsWho this might be right forHerpes SimplexHIV Infections Glaxo Wellcome 30
Testing effectiveness (Phase 2)UnknownNCT03595995What this trial is testingTrial to Evaluate the Safety and Efficacy of UB-621Who this might be right forGenital Herpes United BioPharma 80
Not applicableStudy completedNCT04950712What this trial is testingAn Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.Who this might be right forHerpes Genitalis GlaxoSmithKline 537
Post-approval studies (Phase 4)Study completedNCT00116844What this trial is testingVALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.Who this might be right forInfections, Herpesviridae GlaxoSmithKline 73
Large-scale testing (Phase 3)Study completedNCT00171990What this trial is testingEfficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital HerpesWho this might be right forRecurrent Genital Herpes Novartis 1,461
Post-approval studies (Phase 4)Study completedNCT00306293What this trial is testingVALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2Who this might be right forHerpes Labialis GlaxoSmithKline 70